Noninvasive parameters including NT-proBNP, GDF-15, and LA volume index predicted left atrial low-voltage areas <5% (C-statistic 0.775) and >30% (C-statistic 0.752) in AF patients (both p<0.001).
Observational (n=150)
No
Can non-invasive markers predict the area of low-voltage areas in the left atrium in patients with non-valvular atrial fibrillation referred for primary radiofrequency ablation?
Non-invasive clinical, echocardiographic, and biomarker parameters can reliably predict the extent of left atrial low-voltage areas in patients with non-valvular atrial fibrillation prior to ablation.
Estimación del efecto: C-statistic 0.775 and 0.752
valor p: p=<0.001
Aim. To develop a method for predicting the area of low-voltage area (LVA) in the left atrium (LA), associated with the minimum and maximum expected effectiveness of primary radiofrequency ablation (RFA) in patients with non-valvular atrial fibrillation (AF) using non-invasive predictors. Methods. A longitudinal single-center study included 150 symptomatic non-valvular AF pts aged 20-72 years (median 59.0 51.0; 64.0), including 63 women (42%) hospitalized for primary RFA; 119 pts (79.3%) had paroxysmal and 31 (20.7%) - persistent AF. All pts initially underwent general clinical examination, transesophageal and advanced transthoracic echocardiography, estimation of NT-proBNP (pg/ml) and growth differentiation factor 15 (GDF-15, pg/ml) in the blood. Electroanatomical mapping was performed in sinus rhythm before RFA. The area of LVA (50% in all pts. Results. LVA area varied from 0 to 95.3%, median was 13.7% 5.1; 30.9. Depending on LVA area, pts were divided into 3 groups: 36 pts (30%) in gr. 3. Increase of LVA area was associated with age, presence, and severity of congestive heart failure (CHF), persistent AF, CHA 2 DS 2 -VASc score ≥3 points, increase of LA volume, LV hypertrophy and increase of NT-proBNP and GDF-15 levels. In univariate analysis, LVA area 30 % was associated with age >60 years, NT-proBNP >125 pg/ml, GDF-15 >840 pg/ml, persistent AF, presence of LV hypertrophy, LVEF ≤60%, LA volume index ≥ 32 ml/m 2 . Independent predictors of LVA >30% were: LA volume index ≥32 ml/m 2 , GDF-15 >840 pg/ml, and LVEF ≤60%. The model was of good quality, C-statistics was 0.752 (p<0.001). Conclusion. Evaluation of noninvasive parameters, including clinical characteristics, echocardiographic parameters, and blood levels of NT-proBNP and GDF-15, allows prediction of electroanatomical substrate in left atrium in pts with non-valvular AF referred to primary RFA.
Гизатулина et al. (Mon,) conducted a observational in non-valvular atrial fibrillation (n=150). Non-invasive predictors (NT-proBNP, GDF-15, echocardiography) was evaluated on Prediction of low-voltage area (LVA) <5% and >30% (C-statistic 0.775 and 0.752, p=<0.001). Noninvasive parameters including NT-proBNP, GDF-15, and LA volume index predicted left atrial low-voltage areas <5% (C-statistic 0.775) and >30% (C-statistic 0.752) in AF patients (both p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: